News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Skyhawk Therapeutics Reports Positive Results for SKY-0515 in Huntington's Disease Phase I Trial, Demonstrating Up to 72% Reduction in Huntingtin Protein mRNA
Friday, July 12, 2024Skyhawk Therapeutics Inc has announced positive results from Parts A and B of its Phase clinical trial
AusperBio's AHB-137 Receives Breakthrough Therapy Designation for Chronic Hepatitis B Treatment
Thursday, July 11, 2024AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd have announced that their investigational drug AHB has received Breakthrough Therapy Designation
XyloCor and SmartCella Collaborate on License Agreement for Extroducer in Novel Gene Therapy XC001 Targeting Heart Treatment
Thursday, July 11, 2024XyloCor Therapeutics Inc a company advancing gene therapies for cardiovascular diseases has partnered with SmartWise a unit of SmartCella Holding AB to license the Extroducer Infusion Catheter
Curium Submits NDA for Lutetium Lu 177 Dotatate Injection
Wednesday, July 10, 2024Curium a leader in nuclear medicine announced today the submission of a b New Drug Application for Lutetium Lu Dotatate Injection This application seeks FDA approval for treating somatostatin receptorpositive gastroenteropancreatic neuroendocrine tu...
Abata Therapeutics Gets FDA Approval to Start Clinical Trials of ABA-101 for Progressive Multiple Sclerosis
Tuesday, July 09, 2024Abata Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug application to conduct a Phase study of ABA in patients
RS BioTherapeutics and University of Colorado School of Medicine Announce Research Collaboration
Monday, July 08, 2024RS BioTherapeutics has entered into a collaboration with the University of Colorado School of Medicine to evaluate their novel steroidfree therapeutic platform RSBT for treating lethal lung diseases
AusperBio Reports Significant Progress in Advancing AHB-137 Clinical Development
Friday, July 05, 2024AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd a biotechnology firm specializing in oligonucleotide therapies have made significant strides in developing AHB their lead candidate for treating chronic hepatitis B CHB infection
Pentixapharm Completes Acquisition of Glycotope's Target Discovery Division
Thursday, July 04, 2024Pentixapharm AG a clinicalstage biotech company specializing in developing targeted radiopharmaceuticals for treating cancer has acquired Glycotope GmbHs target discovery business effective July st This acquisition includes a portfolio of preclinical...
Owkin Expands AI-Biotech Presence into Germany, Austria, and Switzerland to Enhance Research Acceleration
Wednesday, July 03, 2024Owkin a prominent AIbiotech firm has expanded into the DACH region by forming partnerships with nine leading institutions These include Charit Universittsmedizin Berlin
Radionetics Oncology and Lilly Enter Strategic Agreement
Tuesday, July 02, 2024Radionetics Oncology a biotechnology company focused on developing innovative small molecule radiopharmaceuticals for targeting G proteincoupled receptors to treat solid tumors has announced a strategic partnership with Eli Lilly and Company The coll...
